OnKure Therapeutics, Inc. (OKUR) — Cash Flow Quality Index

Latest as of December 2023: 0.51x

OnKure Therapeutics, Inc. (OKUR) has a Cash Flow Quality Index of 0.51x as of December 2023. Operating cash flow of $9.38 Million is below net income of $18.52 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore OnKure Therapeutics, Inc. (OKUR) cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

0.51x

Operating CF / Net Income

Operating Cash Flow

$9.38 Million

USD

Net Income

$18.52 Million

USD

Data as of

Dec 2023

Most recent filing

Annual Cash Flow Quality Index for OnKure Therapeutics, Inc. (None–None)

Year-by-year earnings quality comparison for OnKure Therapeutics, Inc.. For live market cap and the full company financial profile, see OKUR market cap overview.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.